Cargando…

Genome engineering of isogenic human ES cells to model autism disorders

Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Refugio A., Stein, Jason L., Krostag, Anne-Rachel F., Nelson, Angelique M., Marken, John S., Menon, Vilas, May, Ryan C., Yao, Zizhen, Kaykas, Ajamete, Geschwind, Daniel H., Grimley, Joshua S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446412/
https://www.ncbi.nlm.nih.gov/pubmed/25765640
http://dx.doi.org/10.1093/nar/gkv164
_version_ 1782373418804445184
author Martinez, Refugio A.
Stein, Jason L.
Krostag, Anne-Rachel F.
Nelson, Angelique M.
Marken, John S.
Menon, Vilas
May, Ryan C.
Yao, Zizhen
Kaykas, Ajamete
Geschwind, Daniel H.
Grimley, Joshua S.
author_facet Martinez, Refugio A.
Stein, Jason L.
Krostag, Anne-Rachel F.
Nelson, Angelique M.
Marken, John S.
Menon, Vilas
May, Ryan C.
Yao, Zizhen
Kaykas, Ajamete
Geschwind, Daniel H.
Grimley, Joshua S.
author_sort Martinez, Refugio A.
collection PubMed
description Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others are multigenic such as the microdeletion and microduplication syndromes of the 16p11.2 chromosomal locus. Here, we report engineered human embryonic stem cell (hESC) lines for modeling these two disorders using locus-specific endonucleases to increase the efficiency of homology-directed repair (HDR). We developed a system to: (1) computationally identify unique transcription activator-like effector nuclease (TALEN) binding sites in the genome using a new software program, TALENSeek, (2) assemble the TALEN genes by combining golden gate cloning with modified constructs from the FLASH protocol, and (3) test the TALEN pairs in an amplification-based HDR assay that is more sensitive than the typical non-homologous end joining assay. We applied these methods to identify, construct, and test TALENs that were used with HDR donors in hESCs to generate an isogenic TS cell line in a scarless manner and to model the 16p11.2 copy number disorder without modifying genomic loci with high sequence similarity.
format Online
Article
Text
id pubmed-4446412
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44464122015-06-15 Genome engineering of isogenic human ES cells to model autism disorders Martinez, Refugio A. Stein, Jason L. Krostag, Anne-Rachel F. Nelson, Angelique M. Marken, John S. Menon, Vilas May, Ryan C. Yao, Zizhen Kaykas, Ajamete Geschwind, Daniel H. Grimley, Joshua S. Nucleic Acids Res Methods Online Isogenic pluripotent stem cells are critical tools for studying human neurological diseases by allowing one to study the effects of a mutation in a fixed genetic background. Of particular interest are the spectrum of autism disorders, some of which are monogenic such as Timothy syndrome (TS); others are multigenic such as the microdeletion and microduplication syndromes of the 16p11.2 chromosomal locus. Here, we report engineered human embryonic stem cell (hESC) lines for modeling these two disorders using locus-specific endonucleases to increase the efficiency of homology-directed repair (HDR). We developed a system to: (1) computationally identify unique transcription activator-like effector nuclease (TALEN) binding sites in the genome using a new software program, TALENSeek, (2) assemble the TALEN genes by combining golden gate cloning with modified constructs from the FLASH protocol, and (3) test the TALEN pairs in an amplification-based HDR assay that is more sensitive than the typical non-homologous end joining assay. We applied these methods to identify, construct, and test TALENs that were used with HDR donors in hESCs to generate an isogenic TS cell line in a scarless manner and to model the 16p11.2 copy number disorder without modifying genomic loci with high sequence similarity. Oxford University Press 2015-05-26 2015-03-11 /pmc/articles/PMC4446412/ /pubmed/25765640 http://dx.doi.org/10.1093/nar/gkv164 Text en © The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Methods Online
Martinez, Refugio A.
Stein, Jason L.
Krostag, Anne-Rachel F.
Nelson, Angelique M.
Marken, John S.
Menon, Vilas
May, Ryan C.
Yao, Zizhen
Kaykas, Ajamete
Geschwind, Daniel H.
Grimley, Joshua S.
Genome engineering of isogenic human ES cells to model autism disorders
title Genome engineering of isogenic human ES cells to model autism disorders
title_full Genome engineering of isogenic human ES cells to model autism disorders
title_fullStr Genome engineering of isogenic human ES cells to model autism disorders
title_full_unstemmed Genome engineering of isogenic human ES cells to model autism disorders
title_short Genome engineering of isogenic human ES cells to model autism disorders
title_sort genome engineering of isogenic human es cells to model autism disorders
topic Methods Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446412/
https://www.ncbi.nlm.nih.gov/pubmed/25765640
http://dx.doi.org/10.1093/nar/gkv164
work_keys_str_mv AT martinezrefugioa genomeengineeringofisogenichumanescellstomodelautismdisorders
AT steinjasonl genomeengineeringofisogenichumanescellstomodelautismdisorders
AT krostagannerachelf genomeengineeringofisogenichumanescellstomodelautismdisorders
AT nelsonangeliquem genomeengineeringofisogenichumanescellstomodelautismdisorders
AT markenjohns genomeengineeringofisogenichumanescellstomodelautismdisorders
AT menonvilas genomeengineeringofisogenichumanescellstomodelautismdisorders
AT mayryanc genomeengineeringofisogenichumanescellstomodelautismdisorders
AT yaozizhen genomeengineeringofisogenichumanescellstomodelautismdisorders
AT kaykasajamete genomeengineeringofisogenichumanescellstomodelautismdisorders
AT geschwinddanielh genomeengineeringofisogenichumanescellstomodelautismdisorders
AT grimleyjoshuas genomeengineeringofisogenichumanescellstomodelautismdisorders